Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer
Crossref DOI link: https://doi.org/10.1038/bjc.2014.283
Published Online: 2014-06-19
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, S J
Lee, I
Lee, J
Park, C
Kang, W K
License valid from 2014-06-19
Article History
Revised: 7 April 2014
Accepted: 30 April 2014
First Online: 19 June 2014
Competing interests
: The authors declare no conflict of interest.